Cargando…
In vitro-activated tumor-bearing host T cells and the effectiveness of tumor vaccine immunotherapy
BACKGROUND AND OBJECTIVE: Vaccination during periods of lymphopenia may facilitate immune responses to weak self-antigens and enhance antitumor immunity. The objective of this study was to determine the effectiveness of tumor vaccine immunotherapy combined with immune reconstruction using tumor-bear...
Autores principales: | Li, Qi-ling, Gao, Shang-feng, Wang, Yun-ping, Ma, Jun, Feng, Cai-xia, Wang, Ying, Wang, Yue-ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
King Faisal Specialist Hospital and Research Centre
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086645/ https://www.ncbi.nlm.nih.gov/pubmed/22366830 http://dx.doi.org/10.5144/0256-4947.2012.162 |
Ejemplares similares
-
Optimal combination treatment regimens of vaccine and radiotherapy augment tumor-bearing host immunity
por: Zhang, Fayun, et al.
Publicado: (2021) -
Immunotherapy using slow-cycling tumor cells prolonged overall survival of tumor-bearing mice
por: Sun, Qing, et al.
Publicado: (2012) -
Pathological Mobilization and Activities of Dendritic Cells in Tumor-Bearing Hosts: Challenges and Opportunities for Immunotherapy of Cancer
por: Tesone, Amelia J., et al.
Publicado: (2013) -
TRAF6 Regulates the Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Tumor-Bearing Host
por: Song, Ge, et al.
Publicado: (2021) -
Lipid metabolism and tumor immunotherapy
por: Wang, Yue, et al.
Publicado: (2023)